BRISTOL-MYERS SQUIBB COMPANY CECELG-RI 0.87
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
Name | Value |
---|
Revenues | 11.2B |
Cost of Revenue | 2.9B |
Gross Profit | 8.3B |
Operating Expense | 6.4B |
Operating I/L | 4.2B |
Other Income/Expense | -2.3B |
Interest Income | 0.1B |
Pretax | 1.9B |
Income Tax Expense | -0.2B |
Net Income/Loss | 2.1B |
Bristol-Myers Squibb Company Ce
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.